| 6.06 Data as of May 20 |  +0.03 / +0.50%Today’s Change | 2.85 Today|||52-Week Range 9.00 | +39.63% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $174.4M |
QRxPharma Ltd. 194 Miller Street North Sydney New South Wales (nsw) 2060 |
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
| John W. Holaday, PhD | Chief Executive Officer, Executive Director & MD |
| Edward M. Rudnic, PhD | Chief Operating Officer |
| Chris J. Campbell | Chief Financial Officer & Secretary |
| Patricia T. Richards, MD, PhD | Chief Medical Officer |
| Stephen Casey | Vice President-Corporate Development |
.
